CDC nominee defends Kennedy shakeup of vaccine advisers

TruthLens AI Suggested Headline:

"CDC Director Nominee Supports Kennedy's Changes to Vaccine Advisory Committee"

View Raw Article Source (External Link)
Raw Article Publish Date:
AI Analysis Average Score: 7.5
These scores (0-10 scale) are generated by Truthlens AI's analysis, assessing the article's objectivity, accuracy, and transparency. Higher scores indicate better alignment with journalistic standards. Hover over chart points for metric details.

TruthLens AI Summary

During a Senate hearing, Dr. Susan Monarez, the nominee to lead the Centers for Disease Control and Prevention (CDC), defended Health and Human Services Secretary Robert F. Kennedy Jr.'s recent overhaul of the CDC's Advisory Committee on Immunization Practices (ACIP). Monarez argued that the changes were necessary to help restore public confidence in vaccine safety, which has been a growing concern among Americans. The hearing took place on the same day that the newly appointed ACIP convened its first meeting in Atlanta, despite calls from lawmakers to delay the session. Monarez emphasized that the secretary’s decision aimed to ensure that the committee could effectively contribute to rebuilding trust in the CDC, which has faced criticism under Kennedy's leadership. Kennedy had dismissed all previous ACIP members, citing conflicts of interest, and appointed eight new members, some of whom have previously expressed skepticism about vaccine safety. This shakeup has raised alarms among lawmakers, particularly regarding the integrity and expertise of the new panel members.

Monarez, who has a background in microbiology and infectious diseases, indicated her willingness to consider adding more qualified individuals to the ACIP. Although she distanced herself from certain controversial decisions made during the Trump administration, she acknowledged the importance of having highly trained professionals involved in vaccine advisement. Senators, including Bill Cassidy, expressed concerns about the qualifications of the new committee members, particularly in relation to emerging vaccine technologies, such as mRNA. They pressed Monarez to ensure that the panel would include experts with relevant experience in immunology and vaccine development. Throughout the hearing, Monarez reiterated the critical role vaccines play in public health, stating that "vaccines save lives." She was also questioned about various health policies, including fluoride in drinking water, but maintained a neutral stance, emphasizing the importance of oral health without committing to any specific changes under Kennedy's direction.

TruthLens AI Analysis

You need to be a member to generate the AI analysis for this article.

Log In to Generate Analysis

Not a member yet? Register for free.

Unanalyzed Article Content

US Health and Human Services Secretary Robert F. Kennedy Jr.’s recent move to replace a federal panel of vaccine advisers should help restore Americans’ trust in the US Centers for Disease Control and Prevention, the nominee to lead that agency told senators on Wednesday.

Dr. Susan Monarez, President Donald Trump’s pick for CDC director, testified before the Senate Health, Education, Labor and Pensions Committee amidincreasing alarm from lawmakersabout Americans’ eroding confidence in vaccine safety under Kennedy’s leadership of HHS.

The Senate hearing happened the same morning that the CDC’s newly appointed Advisory Committee on Immunization Practicesconvened its first meetingin Atlanta despite calls from lawmakers, including HELP Chairman Bill Cassidy, a Republican from Louisiana, to postpone the meeting.

“The secretary had to make a decision related to ensuring that the ACIP could be supportive of restoring public trust,” Monarez said when asked about the reassembled panel.

Kennedy dismissed all 17 ACIP members this month, citing conflicts of interest. Two days later, henamed eight new members, several of whom had records of criticizing vaccine safety. As of Wednesday morning, one nominee, Dr. Michael Ross, had withdrawn during a federal review of members’ financial holdings.

Monarez, a microbiologist and infectious disease expert who has served across several federal health agencies over the years, said she was not familiar with the details of the shakeup but would be open to placing more people on the committee. Although the CDC director can recommend experts to join ACIP, the HHS secretary ultimately signs off on appointments.

“These are not easy positions to fill,” Monarez said. “It takes a lot of time commitment from some of these highly trained technical experts to want to participate.”

Cassidy and several Democratic senators sought reassurances from Monarez that she would protect ACIP’s integrity as CDC director.

“Part of the concern is that the people on the panel, although scientifically credentialed, no one has the experience of [an] immunization [background] to say, ‘Wait a second: The evidence that you’re presenting, there’s a lot more evidence to say it’s not true.’ That responsibility will fall on you,” Cassidy said, echoing concerns that he shared about the panel Monday and pointing to a specific presentation, slated for Thursday, on the preservative thimerosal in certain vaccines.

Cassidy also brought up mRNA, the technology in widely used Covid-19 vaccines that has early promise in other immunizations and potential therapies. Some vaccine critics, including new ACIP member Dr. Robert Malone, have touted unproven theories that mRNA vaccines can cause cancer and other serious side effects.

“If we turn our back on that platform, we’re turning our back on solutions to Lyme disease, which is terribly debilitating, to HIV, which is a scourge,” Cassidy said. He pressed Monarez to include experts on the ACIP panel who have experience with mRNA and immunology.

She agreed.

“We absolutely need highly trained scientists and professionals to be able to participate,” Monarez said. ACIP “is such a vital part of the CDC. It’s such a vital, vital process.”

The nominee also said several times that “vaccines save lives.”

At other points during the hearing, Monarez distanced herself from other Trump administration directives, including mass layoffs at the CDC and proposals to eliminate certain programs.

Monarez, who served as the CDC’s deputy director from January to March and later as acting director, said repeatedly that she was not familiar with the details of layoffs that stalledlead poisoning prevention effortsoranti-tobacco education campaigns.

Monarez said she was not involved in personnel decisionmaking during those Department of Government Efficiency-led layoff, though she later said she worked with CDC staff to “make sure we were reinforcing” the reduction in force plans.

Kennedy has been critical of the addition of fluoride to public water supplies, but Monarez was more noncommittal when questioned by Maryland Sen. Angela Alsobrooks, a Democrat, about the HHS secretary’s plans to end CDC support of fluoridation in state and local drinking water.

“Fluoride is an important component to oral health,” Monarez said.

Alsobrooks noted that the public water supply in Potomac, Maryland, where Monarez lives, is fluoridated and asked Monarez whether it is safe.

“I believe the water in Potomac, Maryland, is safe,” Monarez replied.

Trump chose Monarez to lead the agency after withdrawing his first nominee, former Florida congressman Dr. Dave Weldon, from consideration. In a public letter after his withdrawal, Weldonaccused Cassidyand Sen. Susan Collins of Maine of cratering his nomination amid concerns over his vaccine views.

Back to Home
Source: CNN